HZI - Helmholtz Centre for Infection Research
Animal Models
- Ref-No.Technology
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
Diagnostics
- Ref-No.Technology
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00328Determination of Biofilm Dynamics via Impedance
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00375CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00396
Novel lectin-targeting conjugates for treatment or diagnosis of bacterial infections
- 02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
Drug Delivery
Immunology/Autoimmune
Infectious Diseases
- Ref-No.Technology
- 02-00303Novel Myxopyronin Analogues and Myxopyronin Genecluster for Mutasynthesis
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
- 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00328Determination of Biofilm Dynamics via Impedance
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
- 02-00337Novel labyrinthopeptins as anti-viral agents
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
- 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
- 02-00373Highly potent small molecules prevent tissue damage following S. aureus infection by inhibiting α-hemolysin
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00375CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
- 02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 02-00378
Overcoming resistance - Novel inhibitors of virulence factor LasB of Pseudomonas aeruginosa
- 02-00387
Novel Darobactin Derivatives - highly active antibacterials against gram-negative bacteria
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00395
Novel derivates of griselimycin and their use as antimycobacterial agents
- 02-00396
Novel lectin-targeting conjugates for treatment or diagnosis of bacterial infections
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
- 02-00402
Novel Inhibitors of Cytomegalovirus
- 02-00405
TRSbait – RNA-mimicry of viral transcription regulator as
antiviral drug - 02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
Medical Devices
Oncology
Other Indications
Research Tools
Software
Vaccines
- Ref-No.Technology
- 02-00116New viral packaging cell line
- 02-00158
Cyclic di-Nucleotides as adjuvants
- 02-00160Hexosylceramides as adjuvants
- 02-00280Innovative lipopeptide-conjugates as mucosal adjuvants - BPPcysPep-MPEG
- 02-00361
Cyclic-di-AMP: a promising adjuvant for neonatal vaccines
- 02-00369
Biodynamers enhance drug delivery
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
Chemical Catalyst
Chemical Synthesis
Animal Models - Immunology/Autoimmune
- Ref-No.Technology
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
Animal Models - Oncology
Therapeutics
- Ref-No.Technology
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
- 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
- 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
- 02-00337Novel labyrinthopeptins as anti-viral agents
- 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
- 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
- 02-00369
Biodynamers enhance drug delivery
- 02-00373Highly potent small molecules prevent tissue damage following S. aureus infection by inhibiting α-hemolysin
- 02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 02-00378
Overcoming resistance - Novel inhibitors of virulence factor LasB of Pseudomonas aeruginosa
- 02-00385Next-Generation Probiotics
- 02-00386
Inhibitors of aconitate decarboxylase 1 – A novel immuno-therapeutic target
- 02-00387
Novel Darobactin Derivatives - highly active antibacterials against gram-negative bacteria
- 02-00395
Novel derivates of griselimycin and their use as antimycobacterial agents
- 02-00396
Novel lectin-targeting conjugates for treatment or diagnosis of bacterial infections
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
Technical Equipment
COVID-19 Related Technologies
- Ref-No.Technology
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00377Low Bandwidth Data Base Synchronization – LBDS
- 02-00405
TRSbait – RNA-mimicry of viral transcription regulator as
antiviral drug
Gene Therapy Tools
- Ref-No.Technology
- 02-00369
Biodynamers enhance drug delivery
